Medication Adherence Improvement: Challenges & Opportunities Leah L. Zullig, PhD, MPH

Medication Adherence Improvement: Challenges & Opportunities Leah L. Zullig, PhD, MPH Center for Health Services Research in Primary Care Durham Vete...
Author: Darren Andrews
1 downloads 2 Views 2MB Size
Medication Adherence Improvement: Challenges & Opportunities

Leah L. Zullig, PhD, MPH Center for Health Services Research in Primary Care Durham Veterans Affairs Medical Center Division of General Internal Medicine Duke University

Disclosures • Veterans Affairs Health Services Research & Development Career Development Award (CDA 13-025) • Pilot Awards: Duke Cancer Institute; Duke Global Health Institute; Duke University O' Brien Center for Kidney Research

4/5 take at least one medication

50%

chronic disease medications are not taken

$318 billion in avoidable spending

Fischer, Michael A., et al. "Primary medication non-adherence: analysis of 195,930 electronic prescriptions." Journal of general internal medicine 25.4 (2010): 284-290. Mahoney, John J., et al. "The unhidden cost of noncompliance." J Manag Care Pharm 14.6b (2008): S1-29. 3 Proprietary and Confidential © Verilogue, Inc. All rights reserved. Express Scripts 2011 Drug Trend Report. Available from: http://digital.turn-page.com/i/70797

Triple Aim of Appropriate Medication Use

Better Population Health Better Individual Health

Better Health Care

Triple Aim of Appropriate Medication Use • More efficient use of public and private resources – Prevention of complications & hospitalizations – Less waste of time & effort

Better Individual Health

Better Health Care

Better Population Health

• Professional, personal, and financial rewards

Defining Medication Adherence

Adherent

Non-Adherent

Types of Medication Non-Adherence

Rx Ordered, But Not Dispensed

Primary

30% of prescriptions are never filled

• Failing to Refill Rx Discontinuation • Refilling Rx to Late • Taking Rx Improperly

Secondary

50%

Persistence

of chronic disease meds Sabate E. 2003. Adherence to Long-Term Therapies: Evidence for Action. WHO. IOM. 2007. Preventing Medication Errors: Quality Chasm Series. National Academies Press. not taken Cramer J, Spilker B. Patient Compliance in Medical Practice and Clinical Trials. New York; 1991:414.

Discontinuation Provider Directed vs.

Patient Directed

Intentional vs.

Unintentional

What we see is not the problem…

Non-Adherence Uninformed Decision-Making Poor Communication

Disengaged Patients Complex Drug Regimens Financial & Cognitive Constraints Mismatched Preferences

…just the tip of hazardous contributing factors.

Mrs. Smith Patient Factors • Financial ability • Time • Cognitive ability • Health literacy • Communication • Social support • Engagement

Mrs. Smith Patient Factors • Financial ability • Time • Cognitive ability • Health literacy • Communication • Social support • Engagement

Clinical Team’s Role • Link to financial assistance • Synchronize Rx refills • Provide reminder tools • Educate about treatment • Counsel & accountability • Suggest peer support • Facilitate self-monitoring

Adherence Improvement Toolbox Reminders Smartphone apps Smart pill bottles Dispenser systems Cuing Literacy interventions Health coaching

Medication synchronization Financial assistance Medication therapy management

Keys to Effective Interventions • Modest effect sizes can be significant if they improve clinical outcomes • A health outcome is the endpoint • No one-size-fits-all intervention • Combinations of 2+ interventions that address different dimensions

Viswanathan, Meera, et al. "Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review." Annals of internal medicine 157.11 (2012): 785-795.

Limitations of the Evidence • Too small and too short • Limited generalizability • Inadequate evaluation of adverse effects • Poor clinical outcomes assessment • Lack of evaluation of individual components • Limited comparability

Multicomponent Interventions

Educational

Behavioral & Motivational

System Level

Phases of Chronic Medication-Taking Initiation

Implementation

Persistence

Level of motivation

Tailored support

Long-term communication

Readiness for change

Motivational interviewing

Self-monitoring

Self-efficacy

Setting goals

Reinforcement

Problem solving

Cuing

Shared decision making

Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. British journal of clinical pharmacology 2012;73:691-705.

Is Technology a Delivery Tool? Technology Categories

Specific Solutions

Example Applications

• • • •

Text messaging Smartphone applications Interactive voice response Electronic health records









Biometric and physical activity monitors Digital scales

Pill-monitoring Technology

• • •

Electronic pill caps Smart blister packaging Digital pills

• •

Measure adherence objectively Understand patients’ medication taking

Online Resources & Social Media

• •

Web-based peer support Condition-specific online support communities Online self-monitoring

• •

Enable patient self-monitoring Develop patients’ social support system

Mobile Health Technology

Electronic Monitors







Provide tailored feedback to multiple patients simultaneously Deliver timely reminders automatically Collect data between clinic visits to inform decision making Inform patient self-monitoring

Zullig, L. L., Peterson, E. D., & Bosworth, H. B. (2013). Ingredients of successful interventions to improve medication adherence. JAMA, 310(24), 2611-2612.

Challenge of Getting Evidence into Practice System Sustainability 5. Keep the system working

Scalability

Sustainability

4. Spread it system-wide

3. Keep it working

Effectiveness Efficacy

2. Show it works in clinical practice

1. Demonstrate that it works

~17 years adapted from Kellam & Langevin 2003, Balas & Boren 2000

Opportunities for Adherence Work • Policies encourage meaningful use of HIT to engage patients • Financial incentives exist to engage patients • Patient-centeredness is well-supported

http://www.ahier.net/2015/04/stage-3-meaningful-use-and-2015-edition.html

Leah L. Zullig, PhD, MPH Center for Health Services Research in Primary Care Durham Veterans Affairs Medical Center Division of General Internal Medicine Duke University Email: [email protected] Tel: 1-919-286-0411 ext. 7586 Fax: 1-919-416-5836